Live Breaking News & Updates on Eurofins Biopharma Services|Page 5

Stay updated with breaking news from Eurofins biopharma services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Eurofins Launches the Second Tranche of a Buy-back Programme of Its Own Shares

Regulatory News: Eurofins (Paris:ERF): Following the announcement on 3 October 2022 to buy-back some of its own shares (ISIN FR0014000MR3) (the "Share Repurchase Plan") and the completion of the ....

Contract Research , European Parliament , Biopharma Contract Development , Euronext Paris Stock Exchange , Company Extraordinary , Company Long , Regulatory News , Eurofins Scientific , Share Repurchase Plan , Extraordinary General Meeting , Long Term Incentive ,

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 November 2022

Regulatory News: Eurofins Scientific SE (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal ....

Regulatory News ,

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 October 2022

Regulatory News: Eurofins Scientific SE (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal ....

Regulatory News ,

Eurofins Scientific SE: Eurofins Celebrates 35 Years of Testing for Life and 25 Years as Best Performing Share Listed in Europe

October marks the 35th anniversary of Eurofins (Paris:ERF). Today, the global leader in bio-analysis with 61,000 staff across a network of 940 laboratories in 59 countries, Eurofins' growth has been ....

France General , Gilles Martin , Euronext Paris Stock Exchange , Eurofins Scientific , Euronext Paris Stock ,